1. Alper, C. A., Abramson, N., Johnston, R. B., Jr., Jandl, J. H., Rosen, F. S., 1970, Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3), N. Engl. J. Med. 282: 349–354.
2. Altman, L. C., Snyderman, R., Oppenheim, J. J., Mergenhagen, S. T., 1973, A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes, J. Immunol. 110: 801–810.
3. Altman, L. C., Mackler, B. F., Chassey, R. M., 1974a, Physiochemical characterization of chemotactic lymphokines produced by human thymus derived (T) and bone marrow derived (B) lymphocytes, J. Reticuloendothel. Soc. 16 (Suppl.): 15a.
4. Altman, L. C., Snyderman, R., Blaese, R. M., 1974b, Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Alrich syndrome, J. Clin. Invest. 54: 486–493.
5. Becker, E. L., 1972, The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a and C567, and a bacterial chemotactic factor to their ability to activate the proesterase I of rabbit polymorphonuclear leukocytes, J. Exp. Med. 135: 376–387.